Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,606 | -52,476 | -25,932 | -88,385 | -47,366 |
| Depreciation Amortization | 961 | 617 | 298 | 1,171 | 1,068 |
| Accounts receivable | N/A | -162 | N/A | -151 | -253 |
| Other Working Capital | 7,538 | -1,556 | -1,340 | 2,029 | 9,143 |
| Other Operating Activity | 13,045 | 8,931 | 4,366 | 21,751 | -769 |
| Operating Cash Flow | $-73,062 | $-44,646 | $-22,608 | $-63,585 | $-38,177 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -11,913 | 7,884 | N/A |
| PPE Investments | -4,178 | -427 | -127 | -101 | -72 |
| Purchase Of Investment | -202,951 | -31,954 | N/A | N/A | N/A |
| Sale Of Investment | 30,779 | N/A | N/A | N/A | 7,884 |
| Other Investing Activity | -982 | -454 | -86 | 0 | 0 |
| Investing Cash Flow | $-177,332 | $-32,835 | $-12,126 | $7,783 | $7,812 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 193,133 | 3,876 | 2,922 | 243,854 | 45,533 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,404 |
| Financing Cash Flow | $193,133 | $3,876 | $2,922 | $243,854 | $46,937 |
| Beginning Cash Position | 306,019 | 306,019 | 306,019 | 117,967 | 117,967 |
| End Cash Position | 248,758 | 232,414 | 274,207 | 306,019 | 134,539 |
| Net Cash Flow | $-57,261 | $-73,605 | $-31,812 | $188,052 | $16,572 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,062 | -44,646 | -22,608 | -63,585 | -38,177 |
| Capital Expenditure | -4,178 | -427 | -127 | -101 | -72 |
| Free Cash Flow | -77,240 | -45,073 | -22,735 | -63,686 | -38,249 |